Drugmakers without MFN pacts are bracing to make onenews2026-01-16T20:48:34+00:00January 16th, 2026|Endpoints News|
Supreme Court will hear Hikma’s ‘skinny label’ fight against Amarinnews2026-01-16T20:06:44+00:00January 16th, 2026|Endpoints News|
Makary talks FDA’s plans to combat China’s biotech growthnews2026-01-16T19:51:37+00:00January 16th, 2026|Endpoints News|
ImmunityBio’s cell therapy posts encouraging early data in rare blood cancernews2026-01-16T16:05:02+00:00January 16th, 2026|Endpoints News|
#JPM26: Sandoz CEO on Ozempic generic launch plans for 2026news2026-01-16T14:42:01+00:00January 16th, 2026|Endpoints News|
European regulators recommended 38 novel drugs in 2025, 15 fewer than the FDAnews2026-01-16T12:10:14+00:00January 16th, 2026|Endpoints News|
Novo Nordisk, BioMarin make AI moves; Bristol Myers welcomes neurology exec from Eisainews2026-01-16T12:00:18+00:00January 16th, 2026|Endpoints News|
New York sues ex-Emergent CEO over insider trading during vaccine manufacturing strugglenews2026-01-15T20:36:02+00:00January 15th, 2026|Endpoints News|
Trump asks Congress to codify ‘most favored nation’ dealsnews2026-01-15T19:10:11+00:00January 15th, 2026|Endpoints News|
